Skip to main content
HANDOK Inc. logo

HANDOK Inc. — Investor Relations & Filings

Ticker · 002390 ISIN · KR7002390003 KO Manufacturing
Open in API
Filings indexed 422 across all filing types
Latest filing 2024-04-22 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 002390

About HANDOK Inc.

https://www.handok.co.kr/en/

Handok Inc. is a total healthcare company that develops, manufactures, and distributes a comprehensive range of healthcare solutions. Its portfolio includes prescription drugs, general medicine, medical devices, and in-vitro diagnostics. The company's core business focuses on therapeutic areas such as diabetes, cardiovascular and musculoskeletal diseases, and psychoneurotic disorders, in addition to human vaccines. Positioning itself as a "Health Innovator," Handok provides products and services aimed at prevention, diagnosis, and health management. The company collaborates with global enterprises and manages the entire value chain from sourcing and development to commercialization.

Recent filings

Filing Released Lang Actions
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and is a '정정신고' (Correction Report) regarding previously granted stock options. It details changes to the list of grantees and the number of shares involved. In the context of financial filings, reports concerning the issuance or modification of stock options, especially those involving directors or employees, are classified as regulatory filings under the RNS category when they do not fit into specific categories like 'Director's Dealing' (which is for personal trades) or 'Share Issue' (which is for general capital changes).
2024-04-22 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a 'Correction Report' (정정신고) regarding a previously filed 'Stock Option Grant' (주식매수선택권 부여에 관한 신고). It details changes to the number of shares granted and the list of recipients. In the context of financial filings, reports concerning the issuance or modification of stock options, warrants, or equity-based compensation plans are classified under 'Share Issue/Capital Change' (SHA) as they represent changes to the company's capital structure and potential future equity dilution.
2024-04-22 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and is a '정정신고' (Correction Report). It details changes to previously granted stock options, including adjustments to the number of shares and the list of recipients. In the context of financial filings, reports regarding stock options, share issuance, or capital structure changes that do not fit into specific categories like 'Director's Dealing' or 'Share Issue' are classified under 'Regulatory Filings' (RNS) as a fallback, or specifically as a capital-related update. Given the nature of the filing as a formal regulatory disclosure to the Financial Services Commission/Korea Exchange, it falls under the RNS category.
2024-04-22 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a 'Correction Report' (정정신고) regarding a previously filed 'Stock Option Grant' (주식매수선택권 부여에 관한 신고). It details changes to the number of shares and the list of recipients for stock options. In the context of financial filings, announcements regarding the issuance, modification, or cancellation of stock options or share-based compensation plans are classified under 'Share Issue/Capital Change' (SHA) as they represent changes to the company's capital structure and equity obligations.
2024-04-22 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a 'Correction Report' (정정신고) regarding a previously filed 'Stock Option Grant' (주식매수선택권 부여에 관한 신고). It details specific amendments to the number of shares and the list of grantees for stock options. In the context of corporate filings, announcements regarding the issuance, modification, or cancellation of stock options or capital-related instruments are classified under 'Share Issue/Capital Change' (SHA).
2024-04-22 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a 'Correction Report' (정정신고) regarding a previously filed 'Stock Option Grant' (주식매수선택권 부여에 관한 신고). It details changes to the number of recipients and the number of shares granted due to cancellations. In the context of financial filings, announcements regarding stock options, share-based compensation, or capital changes that do not fit into specific categories like 'Director's Dealing' or 'Share Issue' are classified under 'Regulatory Filings' (RNS) as a fallback, as it is a formal regulatory disclosure to the Korea Exchange.
2024-04-22 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.